CIGB-300, an anti-CK2 peptide, inhibits angiogenesis, tumor cell invasion and metastasis in lung cancer models.
about
CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target.The synthetic peptide CIGB-300 modulates CK2-dependent signaling pathways affecting the survival and chemoresistance of non-small cell lung cancer cell linesProtein Kinase CK2: Intricate Relationships within Regulatory Cellular Networks.
P2860
CIGB-300, an anti-CK2 peptide, inhibits angiogenesis, tumor cell invasion and metastasis in lung cancer models.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
CIGB-300, an anti-CK2 peptide, ...... astasis in lung cancer models.
@en
CIGB-300, an anti-CK2 peptide, ...... astasis in lung cancer models.
@nl
type
label
CIGB-300, an anti-CK2 peptide, ...... astasis in lung cancer models.
@en
CIGB-300, an anti-CK2 peptide, ...... astasis in lung cancer models.
@nl
prefLabel
CIGB-300, an anti-CK2 peptide, ...... astasis in lung cancer models.
@en
CIGB-300, an anti-CK2 peptide, ...... astasis in lung cancer models.
@nl
P2093
P1433
P1476
CIGB-300, an anti-CK2 peptide, ...... astasis in lung cancer models.
@en
P2093
Alejandro J Urtreger
Carla S Capobianco
Fernando Benavent Acero
Hernan G Farina
Silvio E Perea
Stéfano M Cirigliano
Yasser Perera
P356
10.1016/J.LUNGCAN.2016.05.026
P577
2016-06-01T00:00:00Z